Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

Chapple Christopher R.; Cruz Francisco; Cardozo Linda; Staskin David; Herschorn Sender; Choudhury Nurul; Stoelzel Matthias; Heesakkers John; Siddiqui Emad

首页> 外文期刊>European urology >Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

【24h】

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

机译：M拉释的安全性和疗效：对接受M拉释，抗血清或安慰剂的过度活性膀胱患者大型综合临床试验数据库的分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Mirabegron, a beta 3-adrenoreceptor agonist, is an alternative drug to anti-muscarinics for overactive bladder (OAB) symptoms.

机译：背景：β3-肾上腺素能激动剂的M拉萨比格伦是一种替代药物，用于过度活跃的膀胱（OAB）症状。

著录项

来源
《European urology》 |2020年第1期|共10页
作者
Chapple Christopher R.; Cruz Francisco; Cardozo Linda; Staskin David; Herschorn Sender; Choudhury Nurul; Stoelzel Matthias; Heesakkers John; Siddiqui Emad;
展开▼
作者单位

Royal Hallamshire Hosp Sheffield S Yorkshire England;

Hosp Sao Joao Fac Med Dept Urol Porto Portugal;

Kings Coll Hosp London Dept Urogynaecol London England;

Tufts Univ Sch Med Boston MA 02111 USA;

Univ Toronto Dept Urol Toronto ON Canada;

Astellas Pharma Europe Ltd Chertsey Surrey England;

Astellas Pharma Europe Dept Data Sci Leiden Netherlands;

Radboud Univ Nijmegen Med Ctr Dept Urol Nijmegen Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Antimuscarinics; Beta-3-adrenoreceptor agonists; Efficacy; Mirabegron; Overactive bladder; Safety; Solifenacin;

机译：抗血清素;β-3-肾上腺素摄入剂的激动剂;疗效;m拉萨比克;过度活跃的膀胱;安全;solifenacin;

相似文献

外文文献
中文文献
专利

1. Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo [J] . Chapple Christopher R., Cruz Francisco, Cardozo Linda, European urology . 2020,第1期

机译：M拉释的安全性和疗效：对接受M拉释，抗血清或安慰剂的过度活性膀胱患者大型综合临床试验数据库的分析
2. The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial [J] . Jose E. Batista, Heinz K?lbl, Sender Herschorn, Therapeutic advances in urology. . 2015,第4期

机译：米拉贝隆与索非那新相比因缺乏疗效而对先前过度抗毒蕈碱治疗不满意的膀胱过度活跃患者的疗效和安全性：一项非劣效性，随机，IIIb期临床试验的结果
3. The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis [J] . Lozano-Ortega Greta, Walker David, Rogula Basia, Urology . 2019,第期

机译：Mirabegron和OnaboTulinumtoxina患者以前用抗血清素治疗的过度活性膀胱患者的相对疗效和安全性：网络元分析
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. Editorial commentary on Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron Antimuscarinics or Placebo [O] . Tomonori Yamanishi, Tomohiko Kamasasko, Kanya Kaga, 2020

机译：关于 Mirabegron的安全性和有效性：接受Mirabegron抗毒蕈碱药物或安慰剂治疗的膀胱过度活动症患者的大型综合临床试验数据库的分析的社论评论
7. The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis [O] . Greta Lozano-Ortega, David Walker, Basia Rogula, 2019

机译：Mirabegron和OnaboTulinumtoxina患者以前用抗血清素治疗的过度活性膀胱患者的相对疗效和安全性：网络元分析

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

摘要

著录项

相似文献

相关主题

期刊订阅